BIT 5.26% 2.0¢ biotron limited

$30 Billion Deal, page-4936

  1. WBA
    2,359 Posts.
    lightbulb Created with Sketch. 417
    It took SPL 4 months to report on their covid trial for viraleze, from completing trial to reporting to market
    That trial in uk, this one in Thailand and I'd suggest less resources to compile data and or less experience. Also FDA had input, viraleze not and theirs appeared more basic.
    Don't know how they avoid reporting the results, or bury them. Spinning them different.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.